BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$592M |
| 2 |
GE Aerospace
GE
|
+$441M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$428M |
| 4 |
iShares Semiconductor ETF
SOXX
|
+$423M |
| 5 |
Meta Platforms (Facebook)
META
|
+$387M |
Top Sells
| 1 |
Amazon
AMZN
|
+$892M |
| 2 |
Alibaba
BABA
|
+$816M |
| 3 |
Advanced Micro Devices
AMD
|
+$567M |
| 4 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$494M |
| 5 |
IBM
IBM
|
+$477M |
Sector Composition
| 1 | Technology | 28.65% |
| 2 | Consumer Discretionary | 9.73% |
| 3 | Financials | 9.7% |
| 4 | Healthcare | 9.64% |
| 5 | Communication Services | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3301
iShares JPMorgan EM Corporate Bond ETF
CEMB
$400M
| $45.8K | ﹤0.01% |
1,008
+634
| +170% | +$28.8K |
|
3302
KalVista Pharmaceuticals
KALV
$704M
| $45.7K | ﹤0.01% |
4,041
+1,292
| +47% | +$14.6K |
|
|
MTSR
3303
Metsera, Inc. Common Stock
MTSR
$3.63B
| $45.5K | ﹤0.01% |
1,600
+800
| +100% | +$22.8K |
|
3304
AMC Networks
AMCX
$364M
| $45.5K | ﹤0.01% |
7,252
-73,889
| -91% | -$463K |
|
3305
Atea Pharmaceuticals
AVIR
$240M
| $45.5K | ﹤0.01% |
12,627
-71,734
| -85% | -$258K |
|
3306
Pacific Biosciences
PACB
$369M
| $45.2K | ﹤0.01% |
36,462
-7,359
| -17% | -$9.13K |
|
3307
Editas Medicine
EDIT
$254M
| $44.8K | ﹤0.01% |
20,381
-25,257
| -55% | -$55.6K |
|
|
TSSI
3308
TSS, Inc. Common Stock
TSSI
$431M
| $44.7K | ﹤0.01% |
+1,552
| New | +$44.7K |
|
3309
Cross Country Healthcare
CCRN
$425M
| $44.7K | ﹤0.01% |
3,424
+1,142
| +50% | +$14.9K |
|
3310
RCM Technologies
RCMT
$198M
| $44.6K | ﹤0.01% |
1,892
+579
| +44% | +$13.6K |
|
3311
Ennis
EBF
$464M
| $44.6K | ﹤0.01% |
2,456
+890
| +57% | +$16.1K |
|
3312
ACNB Corp
ACNB
$462M
| $44.4K | ﹤0.01% |
1,036
+374
| +56% | +$16K |
|
3313
OrthoPediatrics
KIDS
$488M
| $44.1K | ﹤0.01% |
2,053
-170
| -8% | -$3.65K |
|
3314
Tango Therapeutics
TNGX
$813M
| $44.1K | ﹤0.01% |
8,609
-38,920
| -82% | -$199K |
|
|
LUXE
3315
LuxExperience B.V. American Depositary Shares, each representing one Ordinary Share
LUXE
$1.26B
| $43.9K | ﹤0.01% |
5,533
-3,810
| -41% | -$30.3K |
|
3316
Invesco Mortgage Capital
IVR
$499M
| $43.9K | ﹤0.01% |
5,599
+2,548
| +84% | +$20K |
|
3317
Civista Bancshares
CIVB
$398M
| $43.9K | ﹤0.01% |
1,891
-12,516
| -87% | -$290K |
|
3318
Bit Digital
BTBT
$945M
| $43.8K | ﹤0.01% |
19,992
+9,946
| +99% | +$21.8K |
|
3319
Costamare
CMRE
$1.49B
| $43.6K | ﹤0.01% |
4,788
-60,095
| -93% | -$547K |
|
3320
Simulations Plus
SLP
$309M
| $43.4K | ﹤0.01% |
2,485
-40,192
| -94% | -$701K |
|
3321
JELD-WEN Holding
JELD
$541M
| $43.3K | ﹤0.01% |
11,051
-20,732
| -65% | -$81.3K |
|
|
EDAP
3322
EDAP TMS
EDAP
$89.4M
| $43.1K | ﹤0.01% |
26,105
-14,400
| -36% | -$23.8K |
|
3323
Taysha Gene Therapies
TSHA
$818M
| $42.9K | ﹤0.01% |
18,591
+6,350
| +52% | +$14.7K |
|
3324
Community Health Systems
CYH
$411M
| $42.7K | ﹤0.01% |
12,561
-98,048
| -89% | -$333K |
|
3325
Consensus Cloud Solutions
CCSI
$533M
| $42.7K | ﹤0.01% |
1,851
-5,512
| -75% | -$127K |
|